Tsontcho Ianchulev - Aug 18, 2022 Form 4 Insider Report for EYENOVIA, INC. (EYEN)

Role
Director
Signature
/s/ Tsontcho Ianchulev
Stock symbol
EYEN
Transactions as of
Aug 18, 2022
Transactions value $
$0
Form type
4
Date filed
8/22/2022, 11:04 AM
Previous filing
Nov 3, 2021
Next filing
Apr 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EYEN Common Stock, par value $.0001 Award $0 +21.3K +3.68% $0.00 601K Aug 18, 2022 Direct F1
holding EYEN Common Stock, par value $.0001 607K Aug 18, 2022 By Private Medical Equity, Inc. F2
holding EYEN Common Stock, par value $.0001 6K Aug 18, 2022 By The Meliora Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYEN Stock Option (right to buy) Award $0 +30.4K $0.00 30.4K Aug 18, 2022 Common Stock 30.4K $1.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that fully vest on the earlier of August 1, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.
F2 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F3 The option becomes exercisable on the earlier of August 1, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control.